Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Microba Ip Pty Limited has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The company's current prosecution activity is focused, involving 1 distinct examiner and 1 distinct art unit. This suggests that the company's active applications are being reviewed within a single specialized technical group. Such concentration allows for a more unified approach to patent prosecution, as the technical review is not fragmented across different departments.
The busiest examiner for the portfolio is CROW, ROBERT THOMAS, who is managing 1 busiest examiner pending office action. This single action constitutes the total of 1 pending office action for the company. With only 1 distinct art unit involved, the company's current patent office interactions are entirely handled by this specific examiner. This alignment allows the applicant to focus their legal and technical arguments on the specific concerns of 1 distinct examiner, which can lead to more predictable outcomes within the Biotechnology & Pharmaceuticals field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CROW, ROBERT THOMAS | 1 | 41.3% | +32.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17252375 | METHODS FOR SAMPLE PREPARATION AND MICROBIOME CHARACTERISATION | CROW, ROBERT THOMAS | 16d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17252375 | METHODS FOR SAMPLE PREPARATION AND MICROBIOME CHARACTERISATION | CROW, ROBERT THOMAS | 16d overdue |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17252375 | METHODS FOR SAMPLE PREPARATION AND MICROBIOME CHARACTERISATION | CROW, ROBERT THOMAS | 1683 | §103§112 | Final Rejection | 16d overdue | Pending | Dec 15, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMicroba Ip Pty Limited has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Robert Thomas Crow has the most, with 1 of Microba Ip Pty Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.